Bristol Myers Squibb EPS beats by $0.16, beats on revenue

August 6, 2020

Bristol Myers Squibb (NYSE:BMY): Q2 Non-GAAP EPS of $1.63 beats by $0.16; GAAP EPS of -$0.04 misses by $1.48.

Revenue of $10.13B (+61.6% Y/Y) beats by $90M.

Revlimid sales of $2.88B vs. consensus of $2.90B.

Shares +4.72% PM.

Press Release

https://seekingalpha.com/news/3601734-bristol-myers-squibb-eps-beats-0_16-beats-on-revenue